Resuming aspirin for cardioprotection after GI bleed tied to 38% cut in CV risk

CHICAGO – New data shine a light on the trade-offs involved in resuming low-dose aspirin therapy for secondary cardiovascular prevention following a lower gastrointestinal bleeding event.

Going...